X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with PLETHICO PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs PLETHICO PHARMA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD PLETHICO PHARMA WYETH LTD/
PLETHICO PHARMA
 
P/E (TTM) x 27.7 -1.1 - View Chart
P/BV x 5.3 0.0 31,915.6% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 WYETH LTD   PLETHICO PHARMA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
PLETHICO PHARMA
Mar-14
WYETH LTD/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,044395 264.5%   
Low Rs81831 2,613.4%   
Sales per share (Unadj.) Rs298.6604.4 49.4%  
Earnings per share (Unadj.) Rs57.232.5 176.2%  
Cash flow per share (Unadj.) Rs58.451.3 113.8%  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.80-  
Book value per share (Unadj.) Rs249.5473.6 52.7%  
Shares outstanding (eoy) m22.7234.08 66.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.10.4 884.6%   
Avg P/E ratio x16.36.6 247.9%  
P/CF ratio (eoy) x15.94.2 384.0%  
Price / Book Value ratio x3.70.5 829.5%  
Dividend payout %29.70-   
Avg Mkt Cap Rs m21,1577,262 291.3%   
No. of employees `0000.5NA-   
Total wages/salary Rs m4001,596 25.1%   
Avg. sales/employee Rs Th13,787.4NM-  
Avg. wages/employee Rs Th813.0NM-  
Avg. net profit/employee Rs Th2,643.3NM-  
INCOME DATA
Net Sales Rs m6,78320,598 32.9%  
Other income Rs m353386 91.3%   
Total revenues Rs m7,13620,984 34.0%   
Gross profit Rs m1,6172,818 57.4%  
Depreciation Rs m27642 4.1%   
Interest Rs m61,593 0.3%   
Profit before tax Rs m1,938969 200.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m632-138 -456.9%   
Profit after tax Rs m1,3011,107 117.5%  
Gross profit margin %23.813.7 174.3%  
Effective tax rate %32.6-14.3 -228.3%   
Net profit margin %19.25.4 356.8%  
BALANCE SHEET DATA
Current assets Rs m6,98418,877 37.0%   
Current liabilities Rs m2,05611,896 17.3%   
Net working cap to sales %72.633.9 214.4%  
Current ratio x3.41.6 214.1%  
Inventory Days Days9936 276.2%  
Debtors Days Days24198 12.1%  
Net fixed assets Rs m2449,861 2.5%   
Share capital Rs m227341 66.7%   
"Free" reserves Rs m5,44112,331 44.1%   
Net worth Rs m5,66816,139 35.1%   
Long term debt Rs m254,706 0.5%   
Total assets Rs m7,90133,146 23.8%  
Interest coverage x353.31.6 21,974.5%   
Debt to equity ratio x00.3 1.5%  
Sales to assets ratio x0.90.6 138.2%   
Return on assets %16.58.1 202.9%  
Return on equity %22.96.9 334.5%  
Return on capital %34.012.3 277.0%  
Exports to sales %0.221.4 1.0%   
Imports to sales %36.315.2 238.7%   
Exports (fob) Rs m154,402 0.3%   
Imports (cif) Rs m2,4653,136 78.6%   
Fx inflow Rs m154,402 0.3%   
Fx outflow Rs m2,6773,184 84.1%   
Net fx Rs m-2,6621,219 -218.5%   
CASH FLOW
From Operations Rs m9232,437 37.9%  
From Investments Rs m317-6,265 -5.1%  
From Financial Activity Rs m-4812,490 -19.3%  
Net Cashflow Rs m759-1,337 -56.8%  

Share Holding

Indian Promoters % 0.0 82.7 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 4.3 262.8%  
FIIs % 7.2 5.5 130.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 7.5 405.3%  
Shareholders   21,978 10,665 206.1%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   BIOCON LTD  CADILA HEALTHCARE  SUVEN LIFE  PANACEA BIOTECH  WOCKHARDT LTD.  

Compare WYETH LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - ELDER PHARMA COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS